Jerry Sweeney
Analyst · Bank of America. Your line is open
Olivia, thank you very much. Good morning, everyone, and thank you all for participating in our third quarter 2021 earnings call. On today's call with me are George Johnstone, our Executive Vice President of Operations; Dan Palazzo, our Vice President and Chief Accounting Officer; and Tom Wirth, our Executive Vice President, and Chief Financial Officer. Prior to beginning, certain information discussed during our call may constitute forward-looking statements within the meaning of the Federal Securities Law. Although, we believe these estimates reflected in these statements are based on reasonable assumptions, we cannot give assurance that the anticipated results will be achieved. For further information on factors that could impact our anticipated results, please reference our press release, as well as our most recent annual and quarterly reports that we file with the SEC. Well, first and foremost, we hope that you and yours continue to be safe, happy, healthy, and engaged. And I think looking at our business, despite reopening delays related to the Delta variant, the office market continues to improve, tour activity, lease negotiations, and deal executions remain on a positive trend line. Our portfolio occupancy has increased to approximately 35%. The predominance of tenants returning has though expanded beyond just small employers as occupancy for tenants 50,000 square feet and below is now over 50%. During our prepared comments, we'll review our third quarter results, discuss progress on our business plan and update you on our recent capital and development activity. Tom will then also provide a financial overview and after that Dan, George, Tom, and I are available to answer any questions you may have. From a portfolio management standpoint, we remain focused on reducing forward rollover and providing a solid platform for growth. These efforts have been successful. We have reduced our forward rollover exposure through 2024 to an average of 6.8%, a slight improvement over last quarter. Our forecasted rollover exposure is now below 10% annually through 2026. Revenue and earnings growth remain a top priority. Key near-term earnings drivers for us are, as you all know, we have several key vacancies that upon lease-up will generate between $0.07 and $0.10 per share of growth. And we're delighted to report that we have now leased about 46% of that targeted square footage and achieved about 45% of that forward revenue growth at an average mark-to-market of 12% cash and 19% GAAP and that income will be substantially in place by the third quarter of 2022, which can create a good growth opportunity for us. Some notable components of that during the quarter, the last 38,000 square feet vacated by SHI in Austin has been leased and we've also signed a replacement lease for the 42,000 square feet tenant in Radnor, Pennsylvania. And lastly, we did sign three new leases at Commerce Square, totaling just shy of 29,000 square feet. We do see clear trend lines of tenants requiring higher quality space which we do think positions our portfolio extremely well. From a financial standpoint for the third quarter, we posted FFO of $0.35 per share, which is 1% per share above consensus estimates, which Tom will walk you through. We've also made excellent progress on all the other components of our 2021 business plan. We do anticipate about 100,000 square feet of positive absorption during the fourth quarter and we will achieve our year-end occupancy and lease percentage guidance ranges. And to reinforce our leasing progress to date, we are increasing our speculative revenue target by $500,000 from our mid-point range of $20.5 million to $21 million, and we are over 99% complete on that revised target. It's important to note that $21 million target that we're now circling is about 15% above the bottom end of our original range and it does reflect ever-improving office market conditions. Looking at some other operating statistics, we also posted great results there for the quarter as well. Tenant retention was above our 2021 business plan range. Of the 59 new deals that we signed this year, the weighted average lease term is 7.8 years, 68% of those lease terms are longer than four years, and our medium lease term has remained fairly consistent with what we were able to achieve in 2018, '19, and in 2020. Third quarter capital cost came in below 8% of generated revenue, so well within our business plan range. Cash mark-to-market was a positive 12% and our GAAP mark-to-market was a positive 16%. Our year-to-date mark-to-market results are above our full-year ranges. However, as we noted on last quarter's call, based on leases already executed and commencing in the fourth quarter with lower mark-to-market results, we will finish the year within our business plan ranges, we also expect that every region will post positive mark-to-market results on both a cash and GAAP basis this year. Our third quarter GAAP same-store NOI was 2% and year-to-date results are within our '21 range, Our third quarter cash same-store NOI was 5.5% and above our 2021 range of 3% to 5%, but again, similar to our mark-to-market dynamic, tenants scheduled to take occupancy later this year will accelerate same-store growth and will enable us to achieve our 2021 business plan ranges. We are still forecasting a '21 year-end debt-to-EBITDA in the range of 6.3 times to 6.5 times. And looking at leasing velocity, we know that everyone is keenly focused on recovery data points and we have several encouraging signs to report. The Philadelphia suburban market produced more than 350,000 square feet of leasing activity in the second quarter, a 42.7% increase quarter-over-quarter. The CBD market also posted 181,000 square feet of leasing activity, and Philadelphia generally is making a strong recovery from the pandemic in comparison to a number of other major American cities. Our vacancy rate is lower than the national average and based upon a major brokerage report, Philadelphia is in the top 10 of all American cities for pandemic recovery as measured by recovery rates and employment, vaccination, and leasing activity. During the quarter, we had a total of over 1,500 virtual tours that inspected over 758,000 square feet in line with second-quarter results. Physical tours were down slightly over the second - from the second quarter and we attribute this really more to the summer months as third quarter physical tours outpace first quarter tours by over 13%. Our overall pipeline stands at 1.6 million square feet, which increased by about 600,000 square feet during the quarter, another good sign up more tenants entering the marketplace. And while these recovery data points are encouraging, they also do compare favorably to the pre-pandemic leasing trends. So our pipeline today is 7% better than our third quarter '19 results. Deal conversion rate was on par with previous quarter results as well. Now, as you might expect and we reported last quarter, median deal cycle time continues to trail pre-pandemic levels by approximately 30 days. But on very positive note, during the quarter, we executed 464,000 square feet of leases, including 347,000 square feet of new leasing activity. We also continue to see two favourable trends that we think positively impact our portfolio. First, quality product does matter. Since the beginning of the pandemic, approximately 100,000 square feet of deals have moved up into Brandywine buildings versus lower quality competitors. Secondly, we have seen approximately 20 tenants expand their premises by approximately 122,000 square feet since the beginning of the pandemic. And looking at our liquidity and dividend coverages, as Tom will report, we have excellent liquidity and anticipate having approximately $550 million available on our line of credit by the end of the year. We have no unsecured bond maturities until 2023, have a weighted average effective rate of 3.73%, and a fully unencumbered wholly-owned asset base. Our dividend remains extremely well covered with a 54% FFO and 81% CAD payout ratio. And as we noted, our five-year dividend growth rate has been 5.3%, while our five-year CAD growth rate has been just shy of 8%, well in excess of our core peer averages. From a capital allocation standpoint, it was frankly another quiet quarter, but we continue to make progress on many other fronts. As part of our land recycling program, we did sell three non-core land parcels generating just shy of $11 million of proceeds and at a $900,000 gain. Also, as we noted in our supplemental package, during the quarter, our $50 million preferred equity investment in two office properties in Austin, Texas were redeemed. We did record a $2.8 million incremental investment income during the quarter due to that early redemption. That $50 million preferred equity generated just shy of 21% internal rate of return during the whole period. Taking a quick look at our development opportunity set, 250 King of Prussia Road, which we noted in our supplemental package, is a 169,000 square feet project under renovation in the Radnor sub-market. That was started in the second quarter and will be wrapped up by the second quarter of 2022. The project will accommodate heavy life science as well as offices. Our cost did increase quarter-over-quarter due to some additional MEP work to facilitate broader life science penetration, as well as us adding an additional generator for power redundancy. Those two items did impact our targeted yields by reducing about 20 basis points. The project, as we noted before, is really the first delivery in our Radnor Life Science Center, which will consist of more than 300,000 of life science space in one of the region's best-performing sub-markets. Our current pipeline for 250 King of Prussia Road totals more than 200,000 square feet, including 51,000 square feet in lease negotiations. Looking at Schuylkill Yards, our Schuylkill Yards West project is on time, on budget for a Q3 2023 delivery. That project will be delivered at 7% blended yield. As you may recall, it consists of 326 apartment units, 200,000 square feet of commercial and life science space, and 9,000 square feet of street-level retail. We have an active pipeline continuing to build on that project and our $56.8 million equity commitment is fully funded. Our partner's equity investment is currently being made and the construction loan that we closed recently really will not have its first funding until the first quarter of 2022. Looking at 405 Colorado in Austin, Texas, this project is now complete. During the quarter, we did increase our lease percentage from 24% to 44%. We do have a growing and active pipeline now that that building has been fully delivered. We did slide our stabilization date a couple of quarters to reflect the timing of these new lease signings, as well as the timing of our targeted pipeline. The 522 space garage did open during the summer and is currently just shy of about 12% occupied and we have signed already 102 monthly contracts since we opened the garage. 3000 Market Street in University City, Philadelphia, is a 91,000 square feet life science renovation as part of our Schuylkill Yards neighborhood. Base building construction is complete. The building is fully leased for 12 years at a development yield of 9.6%. The redevelopment did include increasing the building size from 64,000 to 91,000 by converting below-grade space into labs. This property was placed into service on October 1st. Cira Labs, which we announced a couple of quarters ago, where we partnered with PA Biotech Center to create a 50,000 square foot, 239-seat life science incubator within the Cira Center project. That will be completed later in the fourth quarter and will open January 1, 2022. Since the announcement, we have had great leasing success, and now, stand just shy of 50%, about 49% leased with 118 of that 239 seats leased, and a pipeline with 17 additional proposals aggregating more seats than we have available capacity. So very excited about delivering that project on a substantially pre-leased basis. And just looking at some future development at Schuylkill Yards and Broadmoor, within Schuylkill Yards the life science push really continues. We can develop about 3 million square feet of life science space. We've already delivered 3000 Market, The Bulletin Building, 3151 Market, which is our 424,000 net rentable square feet life science building, is fully designed, ready-to-go, and with a strong leasing pipeline and our goal remains to be able to start that project in early '22 assuming market conditions permit and the pipeline continues to build. At Broadmoor Block A, which consists of 363,000 square feet of office and 341 apartments at a total cost of $321 million, will be starting later in the fourth quarter. We are finalizing documentation, including construction financing with our partner. The first phase of Block F, which is 272 apartment units, will be starting in the same venture format in Q1 of '22, and on the office leasing component, our leasing pipeline right now is slightly over 500,000 square feet with about an additional 1.5 million square feet of inquiries. Just one additional note related to our third quarter earnings cycle. As we outlined last quarter, we would normally have provided '22 guidance for earnings and our business plan and FFO during the third quarter cycle. However, consistent with what we did last year, and based on the continued uncertain business climate, we will announce our '22 guidance on our fourth quarter earnings call. Tom will now provide an overview of our financial results.